Breast Cancer: Mutation Interactions & Drug Resistance
Nearly 30% of women diagnosed with early-stage breast cancer will eventually see their disease return, often after initial successful treatment. This sobering statistic underscores a critical challenge: drug resistance. Now, a wave of research, spearheaded by institutions like Memorial Sloan Kettering Cancer Center, is pinpointing the complex genomic mechanisms that allow breast cancer cells to … Read more